SCHEMBL965028

SCHEMBL965028

O=C(CCl)Nc1cccc(C(F)(F)F)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.70
MEN1 O00255 4/20 0.70
KMT2A Q03164 4/20 0.70
GAA P10253 1/20 0.70
XBP1 P17861 1/20 0.70
NPSR1 Q6W5P4 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.67
ALDH1A1 P00352 4/20 0.65
HDAC3 O15379 1/20 0.63
HDAC1 Q13547 1/20 0.63
HDAC2 Q92769 1/20 0.63
HDAC10 Q969S8 1/20 0.63
HDAC11 Q96DB2 1/20 0.63
HDAC8 Q9BY41 1/20 0.63
HDAC6 Q9UBN7 1/20 0.63
NCOR2 Q9Y618 1/20 0.63
HTT P42858 2/20 0.62
RAB9A P51151 1/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
TP53 P04637 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27923273 0.94 MAPT (0.63) MAPTMEN1KMT2AGAAXBP1
SCHEMBL5142590 0.88 MAPT (0.77) MAPTMEN1KMT2AGAAXBP1
SCHEMBL31236338 0.88 MAPT (0.77) MAPTMEN1KMT2AGAAXBP1
SCHEMBL8657567 0.88 HDAC3 (0.68) MAPTMEN1KMT2AGAAXBP1
SCHEMBL693942 0.85 MAPT (0.72) MAPTMEN1KMT2AGAAXBP1
SCHEMBL26627751 0.85 MAPT (0.72) MAPTMEN1KMT2AGAAXBP1
SCHEMBL693941 0.85 MAPT (0.72) MAPTMEN1KMT2AGAAXBP1
SCHEMBL21856351 0.84 YAP1 (0.69) MAPTMEN1KMT2AGAAXBP1
SCHEMBL27923274 0.84 MEN1 (0.60) MAPTMEN1KMT2AGAAXBP1
SCHEMBL5805718 0.84 MAPT (0.70) MAPTMEN1KMT2AGAAXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107400088-B 1, 3-disubstituted pyrazole derivatives, and preparation method and application thereof 山东大学 2020-04-28 CN claimed
WO-2025215121-A1 HEDGEHOG ACYLTRANSFERASE INHIBITORS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-10-16 WO disclosed
US-20250092067-A1 APT1 and APT2 Inhibitors and Uses Thereof CORNELL UNIVERSITY 2025-03-20 US disclosed
CN-118126030-A Preparation method of pyrazoline-1, 3, 4-oxadiazole thioacetamide derivative and application of pyrazoline-1, 3, 4-oxadiazole thioacetamide derivative as pesticide 贵州大学 2024-06-04 CN disclosed
US-20230337677-A1 ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2023-10-26 US disclosed
US-20230337677-A1 ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2023-10-26 US disclosed
US-20230192644-A1 PIPERIDINE-2,6-DIONES AS SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-06-22 US disclosed
US-20230192644-A1 PIPERIDINE-2,6-DIONES AS SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-06-22 US disclosed
EP-4153175-A1 PIPERIDINE-2,6-DIONES AS SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE Dana-Farber Cancer Institute, Inc. (US) 2023-03-29 EP disclosed
WO-2022246115-A1 APT1 AND APT2 INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2022-11-24 WO disclosed
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2004-02-12 US disclosed
US-20030232836-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2003-12-18 US disclosed
US-20030229094-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2003-12-11 US disclosed
WO-2003099266-A2 ACETAMIDES AND BENZAMIDES THAT ARE USEFUL IN TREATING SEXUAL DYSFUNCTION ABBOTT LABORATORIES (US) 2003-12-04 WO disclosed
US-4567264-A ADRENERGIC BLOCKING AGENTS SYNTEX (U.S.A.) INC. (US) 1986-01-28 US disclosed
US-4558129-A Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade SYNTEX (U.S.A.) INC. (US) 1985-12-10 US disclosed
US-4510142-A ANTIINFLAMMATORY OR ANALGESIC AGNET PIERRE FABRE S.A. (FR) 1985-04-09 US disclosed
US-4499100-A CARDIOUVASCULAR DISORDERS SYNTEX (U.S.A.) INC. (US) 1985-02-12 US disclosed
EP-0126449-A1 Cardioselective aryloxy- and arylthio-hydroxypropyl piperazinyl acetanilides wich affect calcium entry SYNTEX (U.S.A.) INC. (US) 1984-11-28 EP disclosed
US-3972928-A Regulating plant growth with quaternary phosphonium aliphatic carboxamide salts BAYCHEM CORPORATION (US) 1976-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229094-A1 Acetamides and benzamides that are useful in treating sexual dysfunction CATSPER1, CYP19A1, PDE12 MAPT 3896/4885MEN1 2828/4885KMT2A 2169/4885
US-20250092067-A1 APT1 and APT2 Inhibitors and Uses Thereof LYPLA2, LYPLA1, PPT1 MAPT 1005/4885MEN1 1356/4885KMT2A 686/4885
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction CATSPER1, CYP19A1, PDE12 MAPT 3896/4885MEN1 2828/4885KMT2A 2169/4885
US-20230192644-A1 PIPERIDINE-2,6-DIONES AS SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE IKZF2, IKZF1, NUTF2 MAPT 950/4885MEN1 3454/4885KMT2A 166/4885
US-20230337677-A1 ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF DDT, ACHE, AHR MAPT 1631/4885MEN1 3871/4885KMT2A 1545/4885
US-20030232836-A1 Acetamides and benzamides that are useful in treating sexual dysfunction CATSPER1, CYP19A1, PDE12 MAPT 3896/4885MEN1 2828/4885KMT2A 2169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.